Related Experiment Video
Updated: Aug 22, 2025

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
Anaesthesia administered as S(+)-ketamine for cardiac intervention in children with common congenital heart disease
Wenjun Liu1, Fei Xu, Liyong Guo
1Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Insights
The highest dose of S(+)-ketamine (0.6 mg/kg) combined with propofol provided the most effective anesthesia for pediatric congenital heart disease patients undergoing cardiac interventional surgery. This combination demonstrated optimal safety and efficacy.
Area of Science:
- Anesthesiology
- Pediatric Cardiology
- Pharmacology
Background:
- Pediatric congenital heart disease (CHD) patients undergoing cardiac interventional surgery require safe and effective anesthesia.
- Assessing S(+)-ketamine and propofol combinations is crucial for clinical reference.
Purpose of the Study:
- To evaluate the safety and efficacy of different S(+)-ketamine doses combined with propofol for pediatric CHD patients.
- To provide data for guiding clinical anesthesia practices in this population.
Main Methods:
- Sixty pediatric CHD patients were randomized into three groups receiving varying S(+)-ketamine doses (0.4, 0.5, or 0.6 mg/kg) with propofol.
- Hemodynamic parameters (heart rate, mean arterial pressure, pulse oxygen saturation) were monitored throughout anesthesia.
- Propofol dosage and incidence of intraoperative movements, postoperative agitation, and nausea/vomiting were recorded.
Main Results:
- The highest S(+)-ketamine dose (0.6 mg/kg) group showed significantly longer awakening times (P = .039).
- Significant differences in intraoperative propofol use (P = .009) and heart rate variations were observed across groups.
- While intraoperative body movement incidence differed (P = .044), postoperative agitation and nausea/vomiting rates were similar across groups.
Conclusions:
- A dosage of 0.6 mg/kg S(+)-ketamine with propofol is the most effective anesthetic regimen for pediatric CHD patients undergoing cardiac interventional surgery.
- This combination offers a favorable balance of efficacy and safety, supporting its clinical application.
Background:
Safety and efficacy were assessed of different S(+)-ketamine doses combined with propofol administered as anesthesia to common pediatric congenital heart disease (CHD) patients undergoing cardiac interventional surgery to provide reference data as guidance for use in clinical settings.
Methods:
Sixty CHD children admitted to Beijing Anzhen Hospital, Capital Medical University from December 2020 to December 2021 who underwent elective cardiac intervention were assigned to 3 groups (H, L, M, 20 patients/group) using a random number table-based method. Patients received 1% propofol (2 mg/kg) and intravenous injections of S(+)-ketamine (Group L, 0.4 mg/kg; Group M, 0.5 mg/kg; Group H, 0.6 mg/kg) followed by intravenous pumping of 1% propofol (4-6 mg/kg/h). Heart rate (HR), mean arterial pressure, and pulse oxygen saturation were recorded preoperatively (T0), at the time of anesthesia maintenance (T1), at the time of arteriovenous puncture (T2), and when they awakened (T3). Additionally, propofol dose and incidence rates of intraoperative body movement, postoperative agitation, and postoperative nausea/vomiting were recorded.
Results:
For the 3 groups, Group H awakening time was significantly longer than that of Group L (P = .039). Notably, intergroup intraoperative propofol times differed significantly (P = .009). Meanwhile, T0 to T3 intragroup HR values differences were significant (P = .017; P = .001; P = .005, respectively). Group L HR was significantly elevated at T2 relative to T0 (P = .003), Group M HR was significantly elevated at T1 and T2 relative to T0 (P = .019; P = .003, respectively), and Group H HR values were significantly elevated at T1 and T2 relative to T0 (P = .012; P = .005, respectively). At all 4 time points no statistically significant intergroup differences in mean arterial pressure values were observed (P = .587). T1 to T3 pulse oxygen saturation values for all 3 groups were significantly greater than corresponding T0 values. Although intergroup intraoperative body movement incidence differed significantly (P = .044), intergroup differences in awakening time agitation and postoperative nausea/vomiting incidence rates were insignificant (P = .732, P = .887, respectively).
Conclusion:
Use of 0.6 mg/kg S(+)-ketamine with propofol was most effective as anesthesia for common pediatric CHD patients undergoing cardiac interventional surgery.
Related Concept Videos
Parenteral Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Inhalational Anesthetics: Overview
Cardiac Catheterization I: Pre-Procedure Overview
Stages of General Anesthesia

